Ovarian cancer is the fifth leading cause of cancer deaths among women, with a 5-year survival rate of only 47%.

It is estimated that approximately 22,240 new cases of ovarian cancer will be diagnosed in the United States in 2018, with more than 14,000 deaths.

Background

Ovarian cancer is a complex disease that arises from several genetic and environmental factors.

Although several well-established genetic mutations, such as BRCA1 and BRCA2, are associated with an increased risk of ovarian cancer, these mutations only account for a small fraction of ovarian cancer cases. Therefore, there is a need for identifying additional genetic markers to improve risk prediction and early detection of ovarian cancer.

Genetic Markers for Ovarian Cancer Risk

Recent advances in genetic sequencing technologies have enabled the identification of several genetic markers that are associated with an increased risk of ovarian cancer. Here are some of the most promising genetic markers for ovarian cancer risk:.

1. KRAS

KRAS is a gene that is mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain KRAS mutations have a significantly increased risk of ovarian cancer.

2. TP53

TP53 is a tumor suppressor gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain TP53 mutations have a significantly increased risk of ovarian cancer.

3. PTEN

PTEN is a tumor suppressor gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain PTEN mutations have a significantly increased risk of ovarian cancer.

4. MSH6

MSH6 is a DNA repair gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain MSH6 mutations have a significantly increased risk of ovarian cancer.

5. BRIP1

BRIP1 is a DNA repair gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain BRIP1 mutations have a significantly increased risk of ovarian cancer.

6. RAD51C

RAD51C is a DNA repair gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain RAD51C mutations have a significantly increased risk of ovarian cancer.

7. CHEK2

CHEK2 is a gene that plays a role in DNA repair, and mutations in this gene have been associated with an increased risk of several different types of cancer, including ovarian cancer.

8. BARD1

BARD1 is a gene that is involved in DNA repair, and mutations in this gene have been associated with an increased risk of ovarian cancer.

9. LATS1

LATS1 is a tumor suppressor gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain LATS1 mutations have a significantly increased risk of ovarian cancer.

10. CDKN2A

CDKN2A is a tumor suppressor gene that is frequently mutated in many different types of cancer, including ovarian cancer. Some studies have shown that women with certain CDKN2A mutations have a significantly increased risk of ovarian cancer.

Summary

Several genetic markers are associated with an increased risk of ovarian cancer, including KRAS, TP53, PTEN, MSH6, BRIP1, RAD51C, CHEK2, BARD1, LATS1, and CDKN2A.

These genetic markers can be used to improve risk prediction and early detection of ovarian cancer, which may ultimately lead to better outcomes for patients.